Core Insights - CorVel Corporation has been recognized in TIME's America's Growth Leaders 2026 Ranking, highlighting its exceptional growth performance, financial stability, and stock performance [1][2] - The company is the only one in its industry to receive this recognition, emphasizing its leadership, innovation, and commitment to delivering value to partners and shareholders [2] Financial Performance - In the quarter ending September 2025, CorVel achieved a 7% revenue growth to $240 million and a 15% increase in gross profit to $58.2 million [3] - The company is focused on sustaining its growth momentum through investments in workforce development via CorVel University [3] Technological Advancements - CorVel is advancing its AI-driven platforms, such as Care Edge, which provides real-time insights and automates routine tasks to enhance operational efficiency [4] - The company is leveraging emerging technologies, including Agentic AI, to improve efficiency, speed, and scalability in its operations [5] Company Overview - CorVel applies technology, including artificial intelligence and machine learning, to manage episodes of care and related healthcare costs, partnering with various stakeholders in the industry [6]

Revenue Growth - The Company's revenues increased to $239.6 million in the quarter ended September 30, 2025, from $224.4 million in the quarter ended September 30, 2024, an increase of $15.3 million, or 7%[86] - Revenue increased to $474.4 million for the six months ended September 30, 2025, up by $38.3 million or 9% from $436.1 million in the same period in 2024[104] - Patient management services revenues rose to $297.6 million, an increase of $11.2 million or 4%, while network solutions services revenues increased to $176.8 million, up by $27.0 million or 18%[104] Cost and Expenses - Cost of revenues increased to $181.5 million in the quarter ended September 30, 2025, from $173.6 million in the quarter ended September 30, 2024, an increase of $7.8 million, or 5%[87] - General and administrative expense increased to $22.3 million in the quarter ended September 30, 2025, from $22.1 million in the quarter ended September 30, 2024, an increase of $0.2 million, or 1%[88] - General and administrative expenses increased to $43.6 million, up by $1.4 million or 3%, accounting for approximately 9% of revenues[107] Profitability - Income before income tax provision increased to $35.9 million in the quarter ended September 30, 2025, from $28.7 million in the quarter ended September 30, 2024, an increase of $7.2 million, or 25%[89] - Net income increased to $27.9 million in the quarter ended September 30, 2025, from $23.4 million in the quarter ended September 30, 2024, an increase of $4.5 million, or 19.3%[95] - Gross profit increased to $58.2 million in the quarter ended September 30, 2025, from $50.7 million in the quarter ended September 30, 2024, an increase of $7.4 million, or 14.6%[95] - Income before income tax provision increased to $71.2 million, a rise of $14.5 million or 26% compared to $56.7 million in the same period in 2024[108] - Net income for the six months ended September 30, 2025, was $55.1 million, reflecting a 22.6% increase from $45.0 million in the prior year[103] - Gross profit for the six months ended September 30, 2025, was $114.8 million, representing a 16.1% increase from $98.9 million in the prior year[103] Cash Flow - Cash and cash equivalents increased to $207.5 million as of September 30, 2025, up by $36.9 million from $170.6 million as of March 31, 2025[110] - Net cash provided by operating activities rose to $80.0 million, an increase of $17.3 million from $62.7 million in the same period in 2024[114] Taxation - The effective tax rate was 22% for the quarter ended September 30, 2025, compared to 18% for the quarter ended September 30, 2024[89] - The effective tax rate for the six months ended September 30, 2025, was 23%, compared to 21% for the same period in 2024[108] Acquisitions - The Company acquired a privately held technology firm during the quarter ended September 30, 2025, enhancing its bill review process[85] Future Expectations - The company expects general and administrative expenses to remain at approximately 9% to 11% of revenues in future quarters[1]

Core Points - CorVel Corporation is conducting a quarterly earnings release webcast to discuss its financial performance and future projections [1] - The company emphasizes that any forward-looking statements made during the webcast are predictions and actual results may differ materially [1] Company Information - Michael Combs serves as the President and Chief Executive Officer of CorVel Corporation [2]

Financial Data and Key Metrics Changes - Revenues for the September quarter were $240 million, a 7% increase from $224 million in the same quarter of the previous year [5] - Earnings per share (EPS) for the quarter were $0.54, a 20% increase from $0.45 in the same quarter of the prior year, adjusted for a 3-for-1 stock split [5] - The combined effect of one-time events in the September quarter softened the increase in EPS by approximately 9 percentage points [5] - Gross margin and net income reached $28 million, up from $23 million in the previous year [18] - The company repurchased 143,774 shares at a cost of $12.8 million during the quarter, totaling 114.7 million shares repurchased for $854 million since inception [19] Business Line Data and Key Metrics Changes - Patient management services generated approximately $4 million in revenue growth [18] - Network solutions increased by $12 million, primarily due to higher utilization of ancillary care and bill review solutions [18] - The service division is innovating under increasing pricing pressure, focusing on delivering savings and operational efficiencies [13] Market Data and Key Metrics Changes - The workers' compensation labor market is facing a demographic shift, losing experienced professionals faster than new ones are being attracted [9] - The commercial health segment is experiencing elevated pricing pressure, necessitating a focus on savings and operational efficiencies [8] Company Strategy and Development Direction - The company is investing in workforce development through CorVel University to address industry-wide labor challenges [10] - Leveraging agentic AI to enhance productivity, reduce costs, and accelerate decision-making across the enterprise [10][12] - Focus on expanding business with existing partners and enhancing technological expertise through mergers and acquisitions [18] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the challenges in the labor market but sees opportunities in workforce development and technological innovation [9][10] - The commitment to responsible AI principles remains unchanged, emphasizing human expertise directing AI [12] - The company is positioned well for continued product expansion and acquisition opportunities due to a strong and debt-free balance sheet [20] Other Important Information - The company is enhancing claims accuracy and efficiency through new digital communication platforms and AI integration [14][15] - Ongoing product enhancements and strong operational management have generated lower direct costs, allowing revenue growth to outpace expenses [19] Q&A Session Summary - The Q&A session was not detailed in the provided content, and thus no specific questions and answers are available for summary.

Financial Data and Key Metrics Changes - The September quarter revenues were $240 million, a 7% increase from $224 million in the September 2024 quarter [5] - Earnings per share for the quarter ending September 30, 2025, were $0.54, a 20% increase over the prior year's EPS of $0.45 [5] - The combined effect of one-time events in the September quarter softened the increase in EPS by approximately 9 percentage points [5] - Gross margin and net income reached $28 million, up from $23 million in the previous year [18] - The company repurchased 143,774 shares at a cost of $12.8 million during the quarter, totaling 114.7 million shares repurchased for $854 million since inception [19] Business Line Data and Key Metrics Changes - Patient management services generated approximately $4 million in revenue growth [18] - Network solutions increased by $12 million, primarily due to higher utilization of ancillary care and bill review solutions [18] - Recent AI-driven enhancements improved capacity and precision in identifying medical bills and claims with potential savings [13] Market Data and Key Metrics Changes - The workers' compensation field is experiencing a demographic shift, losing experienced professionals faster than attracting replacements [9] - The commercial health segment is facing elevated pricing pressure, necessitating a focus on delivering savings and operational efficiencies [8] Company Strategy and Development Direction - The company is investing in people through CorVel University to address workforce challenges and build the next generation of experts [10] - Leveraging agentic AI to enhance productivity, reduce costs, and accelerate decision-making across the enterprise [10][12] - The focus on expanding the suite of offerings to current partners and enhancing technological expertise through mergers and acquisitions [18] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the challenges in the workers' compensation labor market and the commercial health pricing pressure but sees opportunities in these challenges [8][9] - The commitment to responsible AI principles remains unchanged, focusing on human expertise directing AI [12] - The company is positioned well for continued product expansion and acquisition opportunities due to a strong and debt-free balance sheet [20] Other Important Information - The company’s day sales outstanding improved to 40 days, an improvement of two days compared to the same period a year ago [19] - The quarter-ending cash balance was $207 million [19] Q&A Session Summary - The Q&A session was opened for questions but concluded without any specific inquiries or responses being documented [21][22]

Financial Data and Key Metrics Changes - Revenues for the September quarter were $240 million, a 7% increase from $224 million in the same quarter of the previous year [5] - Earnings per share (EPS) for the quarter were $0.54, reflecting a 20% increase from $0.45 in the prior year [5] - The combined effect of one-time events softened the increase in EPS by approximately 9 percentage points [5] - Gross margin and net income reached $28 million, up from $23 million in the previous year [18] - The company repurchased 143,774 shares at a cost of $12.8 million during the quarter, totaling 69% of the total shares outstanding repurchased to date [19][20] Business Line Data and Key Metrics Changes - Patient management services generated approximately $4 million in revenue growth [18] - Network solutions increased by $12 million, primarily due to higher utilization of ancillary care and bill review solutions [18] - The service division is innovating under increased pricing pressure, focusing on delivering savings and operational efficiencies [13] Market Data and Key Metrics Changes - The workers' compensation labor market is facing a demographic shift, losing experienced professionals faster than new ones can be recruited [9] - The commercial health segment is experiencing elevated pricing pressure, necessitating a focus on savings and operational efficiencies [7] Company Strategy and Development Direction - The company is investing in workforce development through CorVel University to address industry-wide labor challenges [10] - Leveraging agentic AI to enhance productivity, reduce costs, and accelerate decision-making across the enterprise [10][12] - The focus on mergers and acquisitions aims to expand the suite of offerings to current partners and enhance technological expertise [18] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the challenges in the labor market but sees opportunities in workforce development and technological innovation [9][10] - The commitment to responsible AI principles remains unchanged, focusing on human expertise directing AI [12] - The company is positioned well for continued product expansion and acquisition opportunities due to a strong and debt-free balance sheet [20] Other Important Information - The company is enhancing claims accuracy and efficiency through new digital communication platforms and AI-powered tools [14][15] - Ongoing product enhancements and strong operational management have led to lower direct costs, allowing revenue growth to outpace expenses [19] Q&A Session Summary - The Q&A session was opened for questions but concluded without specific inquiries being documented [21]

Financial Performance - Revenues for the quarter ended September 30, 2025, were $240 million, a 7% increase from $224 million in the same quarter of 2024[1] - Earnings per share for the quarter were $0.54, up 20% from $0.45 in the same quarter of the prior year[1] - Gross profit increased 15% to $58.2 million, with a gross margin of 24% compared to $50.7 million in the same quarter of fiscal year 2025[6] - For the six months ended September 30, 2025, revenues were $474 million, a 9% increase from $436 million during the same period in 2024[1] - Net income for the quarter was $27.9 million, compared to $23.4 million in the same quarter of the prior year[8] Cash and Assets - The company exited the quarter with $207 million in cash and cash equivalents, with no borrowings[6] - Total assets as of September 30, 2025, were $611.7 million, an increase from $546.0 million as of March 31, 2025[9] Strategic Initiatives - CorVel is addressing workforce challenges by developing new talent through CorVel U, enhancing retention and service quality[3] - The company is leveraging Agentic AI to improve efficiency and scalability across operations, automating complex processes[4] Shareholder Actions - CorVel repurchased $12.8 million of common stock during the quarter[6]

Core Insights - CorVel Corporation will host a live webcast on November 4, 2025, at 11:30 AM Eastern Time to discuss its upcoming quarterly earnings results and introduce its new Chief Financial Officer, Brian Nichols [1][2]. Financial Performance and Strategic Initiatives - The webcast will include discussions on CorVel's financial performance, strategic initiatives, and future outlook, led by President and CEO Michael Combs and CFO Brian Nichols [2]. Webcast Details - Investors, analysts, and interested parties are encouraged to join the webcast for insights into CorVel's performance, with a dedicated question-and-answer session available for attendees [3][6].

Core Insights - The health care sector is experiencing a trend of oversold stocks, presenting potential buying opportunities for undervalued companies [1][2] Group 1: Oversold Stocks - MoonLake Immunotherapeutics (NASDAQ: MLTX) has an RSI of 21.5, with a stock price drop of approximately 86% over the past month, reaching a 52-week low of $5.95. The stock saw a 13% increase to close at $8.43 [3][7] - CorVel Corp (NASDAQ: CRVL) has an RSI of 27.2, with a stock price decline of around 14% over the past month, hitting a 52-week low of $72.15. The stock rose 0.6% to close at $73.83 [4][7] - Harmony Biosciences Holdings Inc (NASDAQ: HRMY) has an RSI of 28.9, with a stock price decrease of about 24% over the past month, reaching a 52-week low of $26.26. The stock gained 2% to close at $27.28 [4][7] Group 2: Company Updates - MoonLake Immunotherapeutics reported week-16 results from its Phase 3 VELA-1 and VELA-2 trials, using HiSCR75 as the primary endpoint [7] - CorVel's CFO Brandon T. O'Brien stepped down, impacting the company's stock performance [7] - Harmony Biosciences Holdings announced topline results from its Phase 3 RECONNECT Study for ZYN002 in Fragile X syndrome, highlighting a catalyst-rich pipeline and plans for future trials [7]

Core Insights - The health care sector is experiencing a trend of oversold stocks, presenting potential buying opportunities for undervalued companies [1][2] Group 1: Oversold Stocks - MoonLake Immunotherapeutics (NASDAQ: MLTX) has an RSI of 21.5, with a stock price drop of approximately 86% over the past month, reaching a 52-week low of $5.95. Recent price action saw a 13% increase, closing at $8.43 [3][7] - CorVel Corp (NASDAQ: CRVL) has an RSI of 27.2, with a stock price decline of around 14% over the past month, hitting a 52-week low of $72.15. The stock rose 0.6% to close at $73.83 [4][7] - Harmony Biosciences Holdings Inc (NASDAQ: HRMY) has an RSI of 28.9, with a stock price decrease of about 24% over the past month, reaching a 52-week low of $26.26. The stock gained 2% to close at $27.28 [4][7] Group 2: Company Developments - MoonLake Immunotherapeutics reported week-16 results from its Phase 3 VELA-1 and VELA-2 trials, using HiSCR75 as the primary endpoint [7] - CorVel's CFO Brandon T. O'Brien stepped down, impacting the company's stock performance [7] - Harmony Biosciences released topline results from its Phase 3 RECONNECT Study for ZYN002 in Fragile X syndrome, highlighting a catalyst-rich pipeline and plans for future trials [7]